Seeking Alpha

Shares of Alexion Pharmaceuticals (ALXN +2.8%) move higher again today, as rumors still swirl...

Shares of Alexion Pharmaceuticals (ALXN +2.8%) move higher again today, as rumors still swirl about a Roche (RHHBY.OB) takeover. Giving added lift is an article in Seeking Alpha suggesting the stock is poised to move up regardless of any buyout speculation. SA blog contributor Supreme Alpha points out the company has solid EPS and revenue growth rates of 37% and 46% respectively, which he thinks are the real drivers in the stock's outperformance. When you add to that mix a recently boosted FY forecast and the potential for a second drug to come to market, the commentator sees it as a great buying opportunity on its own merits.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs